Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.

PURPOSE Histologic results of complete para-aortic lymphadenectomy were studied in patients treated for stage IB2/II cervical carcinoma who had no para-aortic uptake on [(18)F]fluorodeoxyglucose positron emission tomography combined with integrated computed tomography (FDG-PET/CT). PATIENTS AND METHODS Patients were treated between 2004 and 2006 for stage IB2/II cervical cancer. Magnetic resonance imaging of the abdomen and pelvis and FDG-PET/CT were initially performed. Patients with no para-aortic abnormalities were treated with external pelvic radiation therapy and concomitant chemotherapy followed by utero-vaginal brachytherapy. Para-aortic lymphadenectomy was then performed. FDG-PET/CT images were reviewed by two nuclear medicine specialists. RESULTS Thirty-eight patients were studied. Three patients had histologically proven para-aortic involvement (metastatic nodes with capsular rupture in the para-aortic area), leading to a negative predictive value of 92% for para-aortic nodal involvement. CONCLUSION In this study, three of 38 patients with no para-aortic uptake on [(18)F]FDG-PET/CT imaging had histologically proven para-aortic node involvement. PET/CT imaging without histologic examination of the para-aortic area used to determine radiation therapy fields in stage IB2/II cervical cancer would overlook 8% of patients with histologic para-aortic nodal involvement.

[1]  C. Haie-meder,et al.  Para-Aortic Involvement and Interest of Para-Aortic Lymphadenectomy after Chemoradiation Therapy in Patients with Stage IB2 and II Cervical Carcinoma Radiologically Confined to the Pelvic Cavity , 2007, Annals of Surgical Oncology.

[2]  C. Ottosen,et al.  The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. , 2007, Gynecologic oncology.

[3]  C. Fournier,et al.  Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma. , 2007, Gynecologic oncology.

[4]  T. Yen,et al.  Positron emission tomography imaging for gynecologic malignancy , 2007, Current opinion in obstetrics & gynecology.

[5]  Seok-ki Kim,et al.  Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma , 2006, Cancer.

[6]  F. Fazio,et al.  Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. , 2006, Radiology.

[7]  P. Grigsby,et al.  Preoperative lymph node staging of early‐stage cervical carcinoma by [18F]‐fluoro‐2‐deoxy‐D‐glucose–positron emission tomography , 2005, Cancer.

[8]  K. Kang,et al.  Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: a prospective surgicopathologic correlation study. , 2005, European journal of cancer.

[9]  C. Snyderman,et al.  Head and neck malignancy: is PET/CT more accurate than PET or CT alone? , 2005, Radiology.

[10]  Thomas Beyer,et al.  Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  P. Grigsby,et al.  Lymph node control in cervical cancer. , 2004, International journal of radiation oncology, biology, physics.

[12]  P. Grigsby,et al.  Occult supraclavicular lymph node metastasis identified by FDG-PET in patients with carcinoma of the uterine cervix. , 2003, Gynecologic oncology.

[13]  G. V. von Schulthess,et al.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.

[14]  Y. Hung,et al.  Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings. , 2003, Gynecologic oncology.

[15]  K. Ng,et al.  Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. , 2003, Gynecologic oncology.

[16]  R. Wahl,et al.  Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy. , 2002, Gynecologic oncology.

[17]  Paul Symonds,et al.  Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis , 2001, The Lancet.

[18]  F Dehdashti,et al.  Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  B. Goff,et al.  Impact of surgical staging in women with locally advanced cervical cancer. , 1999, Gynecologic oncology.

[20]  C. Haie-meder,et al.  Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. , 1999, Gynecologic oncology.

[21]  K. Holcomb,et al.  The impact of pretreatment staging laparotomy on survival in locally advanced cervical carcinoma. , 1999, European journal of gynaecological oncology.

[22]  L. Adler,et al.  Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  P. Morice,et al.  Lymphatic Spread in Stage Ib and II Cervical Carcinoma: Anatomy and Surgical Implications , 1998, Obstetrics and gynecology.

[24]  M R Segal,et al.  Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. , 1997, JAMA.

[25]  William T. Creaseman Modifications in the staging for Stage I vulvar and Stage I cervical cancer , 1995, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.